Evidence map›Paper›PMID 38234894›Full record

ArticleHeliyon2024

The effect of limited healthcare access on poor outcomes among hospitalized COVID-19 patients in Honduras: A single center cohort study.

César Alas-Pineda, David Aguilar-Andino, Francisco Antonio Vallecillo Munguia, Gissela María Padilla David, Andrea N Umaña, Luis Romero Reyes, Alejandro Cárcamo, Ana Liliam Osorio, Julio Zuniga-Moya, Eleazar Montalvan-Sanchez and 5 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

César Alas-PinedaFacultad de Medicina y Cirugía, Universidad Católica de Honduras - Campus San Pedro y San Pablo, San Pedro Sula, Cortés, Honduras.
David Aguilar-AndinoEscuela Universitaria de Ciencias de la Salud, Universidad Nacional Autónoma de Honduras en el Valle de Sula, San Pedro Sula, Honduras.
Francisco Antonio Vallecillo MunguiaHospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras.
Gissela María Padilla DavidHospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras.
Andrea N UmañaFacultad de Medicina y Cirugía, Universidad Católica de Honduras - Campus San Pedro y San Pablo, San Pedro Sula, Cortés, Honduras.
Luis Romero ReyesHospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras.
Alejandro CárcamoHospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras.
Ana Liliam OsorioHospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras.
Julio Zuniga-MoyaDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Eleazar Montalvan-SanchezDepartment of Medicine, School of Medicine, Indiana University, IN, USA.
Travis J AtchleyDepartment of Neurosurgery, School of Medicine, University of Birmingham at Alabama, AL, USA.
Nicholas Michael Berry LaskayDepartment of Neurosurgery, School of Medicine, University of Birmingham at Alabama, AL, USA.
Dagoberto Estevez-OrdonezDepartment of Neurosurgery, School of Medicine, University of Birmingham at Alabama, AL, USA.
Orlando GarnerClinical Assistant Professor, Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, TX, USA.
Dalton Argean NorwoodEscuela Universitaria de Ciencias de la Salud, Universidad Nacional Autónoma de Honduras en el Valle de Sula, San Pedro Sula, Honduras.
Honduras Foundation for Agricultural Research · HNUniversity of Alabama at Birmingham · USNational Autonomous University of Honduras · HNDepartamento de Epidemiología · GTIndiana University · USTexas Tech University · USUniversidad Católica de Honduras Nuestra Señora Reina de la Paz · HNUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic has had a severe impact on the Latin American subcontinent, particularly in areas with limited hospital resources and a restricted Intensive Care Unit (ICU) capacity. This study aimed to provide a comprehensive description of the clinical characteristics, outcomes, and factors associated with survival of COVID-19 hospitalized patients in Honduras. Research question: What were the characteristics and outcomes of COVID-19 patients in a large referral center in Honduras? Study design and methods: This study employed a retrospective cohort design conducted in a single center in San Pedro Sula, Honduras, between October 2020 to March 2021. All hospitalized cases of confirmed COVID-19 during this timeframe were included in the analysis. Univariable and multivariable survival analysis were performed using Kaplan-Meier curves and Cox proportional hazards model aiming to identify factors associated with decreased 30 day in-hospital survival, using a priori-selected factors. Results: A total of 929 confirmed cases were identified in this cohort, with males accounting for 55.4 % of cases. The case fatality rate among the hospitalized patients was found to be 50.1 % corresponding to 466 deaths. Patients with comorbidities such as hypertension, diabetes, obesity, chronic kidney disease, chronic obstructive pulmonary disease and cardiovascular disease had a higher likelihood of mortality. Additionally, non-survivors had a significantly longer time from illness onset to hospital admission compared to survivors (8.2 days vs 4.7 days). Among the cohort, 306 patients (32.9 %) met criteria for ICU admission. However, due to limited capacity, only 60 patients (19·6 %) were admitted to the ICU. Importantly, patients that were unable to receive level-appropriate care had lower likelihood of survival compared to those who received level-appropriate care (hazard ratio: 1.84). Interpretation: This study represents, the largest investigation of in-hospital COVID-19 cases in Honduras and Central America. The findings highlight a substantial case fatality rate among hospitalized patients. In this study, patients who couldn't receive level-appropriate care (ICU admission) had a significantly lower likelihood of survival when compared to those who did. These results underscore the significant impact of healthcare access during the pandemic, particularly in low- and middle-income countries.

Indexed as

COVID-19ICU shortageLow-and-middle income countryMortality

Identifiers

PMID38234894
PMCPMC10792576
OpenAlexW4390563440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.